Cargando…
Intramyocardial delivery of bFGF with a biodegradable and thermosensitive hydrogel improves angiogenesis and cardio-protection in infarcted myocardium
Basic fibroblast growth factor (bFGF), a known angiogenic factor, may provide a potential strategy for the treatment of myocardial infarction (MI), but it is limited by a relatively short half-life. Dex-PCL-HEMA/PNIPAAm hydrogel provides a reservoir for the controlled release of growth factors. The...
Autores principales: | Zhu, Hongling, Li, Xiaoyan, Yuan, Mingjie, Wan, Weiguo, Hu, Miaoyang, Wang, Xiaoding, Jiang, Xuejun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5639332/ https://www.ncbi.nlm.nih.gov/pubmed/29042955 http://dx.doi.org/10.3892/etm.2017.5015 |
Ejemplares similares
-
Thermosensitive heparin‐poloxamer hydrogel encapsulated bFGF and NGF to treat spinal cord injury
por: Hu, Xiaoli, et al.
Publicado: (2020) -
Thermosensitive bFGF-Modified Hydrogel with Dental
Pulp Stem Cells on Neuroinflammation of Spinal Cord Injury
por: Albashari, Abdullkhaleg, et al.
Publicado: (2020) -
MMP-sensitive PEG hydrogel modified with RGD promotes bFGF, VEGF and EPC-mediated angiogenesis
por: Ouyang, Liu, et al.
Publicado: (2019) -
MMP 9-instructed assembly of bFGF nanofibers in ischemic myocardium to promote heart repair
por: Wang, Yaguang, et al.
Publicado: (2022) -
Regulation of bFGF gene expression and subcellular distribution of bFGF protein in adrenal medullary cells
Publicado: (1994)